Table 2.
Surgery characteristics of the included studies
| Author, year | Type of cardiac surgery | Cardiopulmonary bypass | Cardiopulmonary bypass duration | Vasoactive agents | ||
|---|---|---|---|---|---|---|
| Patient without IAPIs | Patient with IAPIs | Patient without IAPIs | Patient with IAPIs | |||
| Cai et al. [3] | VDH, CHD | On-pump | 48.9 ± 23.1 | 48.9 ± 23.1 | 30/82 | 9/28 |
| Shih et al. [4] | Elective cardiac surgery | NA | NA | NA | NA | NA |
| Lu et al. [12] | CHD, VDH, CAD, TAA | On-pump | 48.9 ± 36.0 | 48.9 ± 23.1 | 30/82 | 9/28 |
| Shokati et al. [28] | Elective cardiac surgery | NA | NA | NA | NA | NA |
| Ramezanpour et al. [25] | CABG, VDH, combined coronary and valve procedures | NA | NA | NA | NA | NA |
| Schuurman et al. [26] | Elective cardiac surgery | NA | NA | NA | NA | NA |
| Thomas et al. [29] | CABG | On-pump | 114 ± 43 | 129 ± 40 | NA | NA |
| Papantonio et al. [24] | Elective cardiac surgery | On-pump | 103.7 ± 35.3 | 114.5 ± 32.8 | NA | NA |
| Huang et al. [23] | MVR, AVR, DVR, CABG, Bentall procedure | On-pump | NA | NA | NA | NA |
| Shaw et al. [27] | Elective cardiac surgery | NA | NA | NA | NA | NA |
MVR mitral valve replacements; AVR aortic valve replacements; DVR double valve replacements; CABG coronary artery bypass grafting; TAA thoracic aortic aneurysms; CHD congenital heart disease, VDH valvular disease of the heart; CAD coronary artery disease; Pro prospective; NA not available